Merck EBIT 2010-2024 | MRK

Merck EBIT for the quarter ending September 30, 2024 was $3.984B, a 32.15% decline year-over-year.

  • Merck 2023 EBIT was 2.954B, a 83.84% decline from 2022.
  • Merck 2022 EBIT was 18.282B, a 38.51% increase from 2021.
  • Merck 2021 EBIT was 13.199B, a 137.91% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Merck EBIT 2010-2024 | MRK

  • Merck 2023 EBIT was 2.954B, a 83.84% decline from 2022.
  • Merck 2022 EBIT was 18.282B, a 38.51% increase from 2021.
  • Merck 2021 EBIT was 13.199B, a 137.91% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757B
Novo Nordisk (NVO)$483B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$354.3B
Novartis AG (NVS)$218.9B
AstraZeneca (AZN)$200.6B
Pfizer (PFE)$155.6B
Sanofi (SNY)$131.3B
Innoviva (INVA)$1.3B